About
Obesity & Genetic Metabolic Disorders
Areas of Focus
Categories
Small Molecule PharmaceuticalSan Diego & Southern California
Team (16)
Bryan Jones
Bryan Jones, PhD
Aardvark Therapeutics
team_member
Christian Zapf
Christian Zapf, JD
Aardvark Therapeutics
team_member
Danny Villeneuve
Danny Villeneuve
Aardvark Therapeutics
team_member
Dvorit Samid
Dvorit Samid, PhD
Aardvark Therapeutics
team_member
Jeffrey Chi
Jeffrey Chi, PhD, CFA
Aardvark Therapeutics
team_member
Justin Stege
Justin Stege, PhD
Aardvark Therapeutics
team_member
Clinical Trials (6)
View allTotal Trials
6
As Lead Sponsor
6
As Collaborator
0
Total Enrollment
236
By Phase
PHASE3: 2PHASE2: 4
By Status
COMPLETED: 4RECRUITING: 2
Clinical Trials Pipeline6 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06828861Lead Sponsor
ARD-101 for Treatment of PWS: The Hunger Elimination or Reduction Objective Trial
PHASE3Recruiting
90 participants
Started: Dec 20, 2024 · Completed: Apr 30, 2026
NCT06126653Lead Sponsor
A Study to Evaluate ARD-501 in Patients With Autism Spectrum Disorder
PHASE2Completed
5 participants
Started: Aug 1, 2024 · Completed: Jan 13, 2025
NCT07197034Lead Sponsor
The Hunger Elimination or Reduction Objective (HERO ) Open -Label Extension (OLE) Trial
PHASE3Recruiting
90 participants
Started: Jul 23, 2024 · Completed: Apr 30, 2027
NCT05153434Lead Sponsor
A Study of Oral ARD-101 in Patients With Prader-Willi Syndrome
PHASE2Completed
19 participants
Started: May 27, 2022 · Completed: Sep 24, 2024
NCT05215847Lead Sponsor
Study to Evaluate ARD-101 in Adults Receiving Bariatric Surgery
PHASE2Completed
12 participants
Started: Mar 1, 2022 · Completed: Feb 3, 2023
Locations (1)
Headquarters
San Diego, CA, United States
Map
Loading map...